Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immine response modifier compounds for treatment of TH2 mediated and related diseases

Immine response modifier compounds for treatment of TH2 mediated and related diseases

US Patent 6200592 · Granted Mar 13, 2001

Estimated economic value: $54,169,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Manufacturing a biologic pharmaceutical using causal models2024
Methods and compositions for enhancing immune response2017
Therapeutic combinations and methods including IRM compounds2015
Therapeutic combinations and methods including IRM compounds2015
Formulations containing an immune response modifier2012
Prophylactic treatment of UV-induced epidermal neoplasia2012
Methods for the treatment of periodontal disease2007
Dye labeled imidazoquinoline compounds2005
Immune response modifier compounds for treatment of TH2 mediated and related dis2004
Immune response modifier compounds for treatment of TH2 mediated and related dis2004
Immune response modifier compounds for treatment of TH2 mediated and related dis2004
Dye labeled imidazoquinoline compounds2003